Eledon Pharmaceuticals, Inc. (ELDN)
3.46
+0.05
(+1.47%)
USD |
NASDAQ |
Aug 25, 10:04
Eledon Pharmaceuticals Price to Book Value : 8.478 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 8.355 |
| August 21, 2026 | 8.453 |
| August 20, 2026 | 8.625 |
| August 19, 2026 | 8.698 |
| August 18, 2026 | 8.870 |
| August 17, 2026 | 8.772 |
| August 14, 2026 | 8.674 |
| August 13, 2026 | 9.066 |
| August 12, 2026 | 9.238 |
| August 11, 2026 | 9.188 |
| August 10, 2026 | 9.017 |
| August 07, 2026 | 9.042 |
| August 06, 2026 | 8.478 |
| August 05, 2026 | 8.429 |
| August 04, 2026 | 8.551 |
| August 03, 2026 | 8.404 |
| July 31, 2026 | 8.282 |
| July 30, 2026 | 8.355 |
| July 29, 2026 | 8.110 |
| July 28, 2026 | 8.331 |
| July 27, 2026 | 8.747 |
| July 24, 2026 | 8.772 |
| July 23, 2026 | 9.164 |
| July 22, 2026 | 9.115 |
| July 21, 2026 | 9.678 |
| Date | Value |
|---|---|
| July 20, 2026 | 9.458 |
| July 17, 2026 | 9.973 |
| July 16, 2026 | 9.409 |
| July 15, 2026 | 9.85 |
| July 14, 2026 | 9.924 |
| July 13, 2026 | 9.458 |
| July 10, 2026 | 9.434 |
| July 09, 2026 | 10.12 |
| July 08, 2026 | 10.32 |
| July 07, 2026 | 9.630 |
| July 06, 2026 | 9.728 |
| July 02, 2026 | 9.678 |
| July 01, 2026 | 9.556 |
| June 30, 2026 | 9.654 |
| June 29, 2026 | 6.575 |
| June 26, 2026 | 6.405 |
| June 25, 2026 | 6.185 |
| June 24, 2026 | 6.710 |
| June 23, 2026 | 6.693 |
| June 22, 2026 | 6.456 |
| June 18, 2026 | 6.642 |
| June 17, 2026 | 6.270 |
| June 16, 2026 | 5.897 |
| June 15, 2026 | 5.812 |
| June 12, 2026 | 6.049 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.907 |
| Viking Therapeutics, Inc. | 9.828 |
| ACADIA Pharmaceuticals, Inc. | 3.987 |
| Alnylam Pharmaceuticals, Inc. | 23.46 |
| Anika Therapeutics, Inc. | 2.117 |
Price to Book Value Related Metrics
| Price | 3.46 |
| Earnings Yield | -28.62% |
| Market Cap | 279.88M |